Exelixis
EXEL
#1812
Rank
$11.00 B
Marketcap
$40.88
Share price
-1.23%
Change (1 day)
13.34%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company